Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab Altorki, N., Felip, E., Zhou, C., Vallieres, E., Moiseyenko, V., Smolin, A., Rittmeyer, A., Vereshchako, R., Perol, M., Schutte, W., Fang, J., Tao, M., Teixeira, E., Kim, Y., Gitlitz, B., Bennett, E., Mcnally, V., Wu, F., Deng, Y., Wakelee, H. ELSEVIER SCIENCE INC. 2021: S845-S846
View details for Web of Science ID 000709606500030